CollPlant Biotechnologies (CLGN) Share-based Compensation (2018 - 2025)
CollPlant Biotechnologies' (CLGN) quarterly Share-based Compensation came in at $2.0 million in Q4 2025, up 166.89% YoY from $755373.4 in Q4 2024, and up 614.89% on a QoQ basis from $282000.0 in Q3 2025.
CollPlant Biotechnologies (CLGN) Share-based Compensation (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 8 years of Share-based Compensation data on file, last reported at $2.0 million in Q4 2025.
- Quarterly Share-based Compensation rose 166.89% year-over-year to $2.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$360000.0 (up 79.03% YoY) and the FY2025 annual result came in at $999000.0, up 158.12% from the prior year.
- Share-based Compensation climbed to $2.0 million in Q4 2025, from $282000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $2.0 million in Q4 2025 to a low of -$3.0 million in Q4 2024.
- A 5-year average of $349000.0 and a median of $469000.0 in 2021 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2022 — Share-based Compensation soared 223.24% — and 2024, when it plunged 634.4%.
- Tracing CLGN's Share-based Compensation over 5 years: stood at $275000.0 in 2021, then jumped by 59.64% to $439000.0 in 2022, then climbed by 28.47% to $564000.0 in 2023, then sank by 634.4% to -$3.0 million in 2024, then soared by 166.89% to $2.0 million in 2025.
- The last three Share-based Compensation figures came in at $2.0 million (Q4 2025), $282000.0 (Q3 2025), and $356000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 86.63 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 28.05 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 41.25 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.26 Mn | 4.26 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.02 Mn |
| Dec 31, 2025 | 2.02 Mn |
| Sep 30, 2025 | 282,000.00 |
| Sep 30, 2025 | 282,000.00 |
| Jun 30, 2025 | 356,000.00 |
| Jun 30, 2025 | 356,000.00 |
| Dec 31, 2024 | -3.01 Mn |
| Dec 31, 2024 | -3.01 Mn |
| Sep 30, 2024 | 515,000.00 |
| Sep 30, 2024 | 515,000.00 |
| Jun 30, 2024 | 492,000.00 |
| Jun 30, 2024 | 492,000.00 |
| Mar 31, 2024 | 290,000.00 |
| Mar 31, 2024 | 290,000.00 |
| Dec 31, 2023 | 564,000.00 |
| Dec 31, 2023 | 564,000.00 |
| Sep 30, 2023 | -521,000.00 |
| Sep 30, 2023 | -521,000.00 |
| Jun 30, 2023 | 1.37 Mn |
| Jun 30, 2023 | 1.37 Mn |